Industry News:

Innovaro Pharmalicensing

Latest: Watch here for details of new products and services.

About Us: Innovaro Pharmalicensing - Partnering solutions for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Pay-per-Click New!; Deal Negotiation; PL Intelligence; Reports; Comparison
PL Intelligence: Overview; Industry news; Deals review; Press releases; Articles
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs
Contact Innovaro Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Innovaro Pharmalicensing
is a division of
Innovaro Europe Ltd

Innovaro Corporation

Industry news

Related news

Latest News

ReNeuron signs further stem cell manufacturing contracts with Angel Biotechnology for stroke clinical trial.

Zogenix Initiates Pivotal Phase 3 Clinical Trial for Novel Formulation of Oral Controlled-Release Hydrocodone

Desmoteplase enters clinical phase II in Japan in ischaemic stroke representing Lundbeck's first clinical programme in Japan

FDA Orders 2 Companies to Stop Marketing Unapproved Nitroglycerin Tablets

Icagen Reports Positive Results for ICA-105665 in Patients With Photosensitive Epilepsy

Oculus Innovative Sciences Receives First FDA Clearance for Microcyn

FDA Approves Botox to Treat Spasticity in Flexor Muscles of the Elbow, Wrist and Fingers

Agendia Receives New York State Laboratory Permit and Laboratory Accreditation by College of American Pathologists

NeuroSearch announces new findings from the MermaiHD Phase III study supporting potential disease modifying properties of Huntexil

ISIS Initiates Phase 1 Clinical Trial of ISIS-SOD1Rx in Patients With ALS

More news... | RSS Feed...

Most Viewed

Data from a post hoc analysis using desmoteplase in ischaemic stroke presented at the International Stroke Conference

Agendia Receives New York State Laboratory Permit and Laboratory Accreditation by College of American Pathologists

Novartis oral multiple sclerosis development compound Gilenia

Advanced Cell Technology's RPE Cells Granted Orphan Drug Status from FDA for Treatment of Stargardt's Macular Dystrophy

NeuroSearch announces new findings from the MermaiHD Phase III study supporting potential disease modifying properties of Huntexil

IntelGenx and Cannasat Announce Letter of Intent for Relivar License

Diffusion Pharmaceuticals LLC Announces Publication of Three Studies Testing Trans Sodium Crocetinate (TSC); Statistically significant results seen in animal models of primary brain cancer, cerebral...

FDA Approves Botox to Treat Spasticity in Flexor Muscles of the Elbow, Wrist and Fingers

Icagen Reports Results of Phase Ib Pain Study of ICA-105665

Clients in focus...

Get the Flash Player to see this rotator.

Press releases: Innovaro Pharmalicensing current industry press releases.

Products:	Partnering Search	Pay-per-Click	Company Profiling	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us

© Copyright 1998-2010 Innovaro Pharmalicensing, a division of Innovaro Europe Ltd All rights reserved. Terms and Conditions | Contact us